Literature DB >> 8996367

Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings.

V W Nitti1, Y Kim, A J Combs.   

Abstract

PURPOSE: Persistent voiding dysfunction following transurethral resection of the prostate is not uncommon. We determined the correlation, if any, between the subjective complaints in men with voiding dysfunction after transurethral resection of the prostate and the urodynamic findings.
MATERIALS AND METHODS: A total of 50 consecutive men with voiding dysfunction following transurethral resection of the prostate was evaluated with the American Urological Association symptom index and multichannel urodynamics. Patients with urethral stricture, urinary retention or prostate cancer were excluded from the study. Urodynamic parameters assessed included detrusor instability, bladder capacity, sphincteric insufficiency using the Valsalva leak point pressure, voiding pressure-flow studies as determined by the Abrams-Griffiths nomogram (obstructed, unobstructed or equivocal) and post-void residual.
RESULTS: Mean patient age was 71 years and mean interval from last transurethral resection of the prostate was 58 months (range 2 to 252). Mean total, obstructive and irritative symptom scores were 16.3, 5.8 and 10.5, respectively. A total of 20 patients (40%) complained of incontinence (14 urge and 6 stress). According to the Abrams-Griffiths nomogram 62% of the cases were unobstructed, 16% obstructed and 22% equivocal. Urodynamic abnormalities were demonstrated in 43 patients (86%), and included detrusor instability (54%), obstruction with or without detrusor instability (16%), sphincteric insufficiency (8%), detrusor hypocontractility (4%) and sensory urgency (4%). There was no difference in the total, irritative or obstructive scores among obstructed, unobstructed or equivocal cases. Similarly there was no difference in scores among patients with and without detrusor instability. Age, number of transurethral resections and interval since last transurethral resection were unrelated to pressure-flow results or detrusor instability. Post-void residual was significantly greater in obstructed cases and bladder capacity was significantly less in those with detrusor instability. The cause of incontinence was demonstrated in 19 of 20 patients (95%): 4 (20%) had sphincteric insufficiency and 15 (75%) had detrusor instability.
CONCLUSIONS: Symptoms are unreliable in predicting urodynamic findings with respect to obstruction and detrusor instability. There is a high incidence of detrusor instability in patients with voiding dysfunction after transurethral resection of the prostate. Urodynamic obstruction is a less likely occurrence.

Entities:  

Mesh:

Year:  1997        PMID: 8996367

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  Symptoms and urodynamics after unsuccessful transurethral prostatectomy.

Authors:  I Ignjatovic
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 2.  Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate.

Authors:  Soo Jeong Kim; Omar Al Hussein Alawamlh; Bilal Chughtai; Richard K Lee
Journal:  Curr Urol Rep       Date:  2018-08-20       Impact factor: 3.092

Review 3.  Evaluation and management of post-transurethral resection of the prostate lower urinary tract symptoms.

Authors:  Bilal Chughtai; Vannita Simma-Chiang; Steven A Kaplan
Journal:  Curr Urol Rep       Date:  2014-09       Impact factor: 3.092

4.  Can urinary nerve growth factor be a biomarker for overactive bladder?

Authors:  Hann-Chorng Kuo; Hsin-Tzu Liu; Michael B Chancellor
Journal:  Rev Urol       Date:  2010

Review 5.  The Use of Urodynamics Assessment Before the Surgical Treatment of BPH.

Authors:  Ahmed El-Zawahry; Shaheen Alanee; Angela Malan-Elzawahry
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

6.  Long-lasting bladder overactivity and bladder afferent hyperexcitability in rats with chemically-induced prostatic inflammation.

Authors:  Jianshu Ni; Shinsuke Mizoguchi; Kyrie Bernardi; Takahisa Suzuki; Masahiro Kurobe; Eiichiro Takaoka; Zhou Wang; Donald B DeFranco; Pradeep Tyagi; Baojun Gu; Naoki Yoshimura
Journal:  Prostate       Date:  2019-03-22       Impact factor: 4.104

7.  Adipose-derived stem cells (ADSCs) and muscle precursor cells (MPCs) for the treatment of bladder voiding dysfunction.

Authors:  Mathias Tremp; Souzan Salemi; Remo Largo; Karl-Erik Andersson; Jan A Plock; Jan Plock; Tamer Aboushwareb; Tullio Sulser; Daniel Eberli
Journal:  World J Urol       Date:  2013-11-12       Impact factor: 4.226

8.  Comparative Analysis of Outcomes after Transurethral Resection of the Prostate according to Prostate Shape Shown by Transrectal Ultrasonography.

Authors:  Hyo Serk Lee; Sung Jin Kim; Jae Mann Song; Kwang Jin Kim; Hyun Chul Chung
Journal:  Korean J Urol       Date:  2010-07-20

Review 9.  Urodynamics: what to do and when is it clinically necessary?

Authors:  Matthew P Rutman; Jerry G Blaivas
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

Review 10.  Overactive bladder and men: indications for anticholinergics.

Authors:  Ricardo R González; Alexis E Te
Journal:  Curr Urol Rep       Date:  2003-12       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.